NABI BIOPHARMACEUTICALS
NABI BIOPHARMACEUTICALS (NABI) is a publicly traded company in the Unknown sector. Across all available filings, 19 corporate insiders have executed 250 transactions totaling $14.0M, demonstrating a bearish sentiment with -$1.2M in net insider flow. The most recent transaction on Apr 5, 2012 involved a sale of 5,167 shares valued at $9.8K.
NABI Insider Activity Summary
Who Is Buying NABI Stock?
No significant insider buying has been recorded for NABI in the recent period.
Who Is Selling NABI Stock?
No significant insider selling has been recorded for NABI in the recent period.
Is NABI BIOPHARMACEUTICALS Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for NABI is bearish with an Insider Alignment Score of 46/100 and a net flow of -$1.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
NABI Frequently Asked Questions
Understanding NABI Insider Activity
Insider trading at NABI BIOPHARMACEUTICALS (NABI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 19 insiders are actively trading NABI stock, having executed 250 transactions in the past 90 days. The most active insider is Daniel S. Loeb (Executive), who has made 5 transactions totaling $5.9M.
Related Tools
Track NABI BIOPHARMACEUTICALS Insider Activity
Get notified when executives and directors at NABI file new Form 4 transactions